RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Formulation and in vitro studies of a fixed-dose combination of a bilayer matrix tablet containing metformin HCl as sustained release and glipizide as immediate release.

Formulation and in vitro studies of a fixed-dose combination of a bilayer matrix tablet containing metformin HCl as sustained release and glipizide as immediate release.

Add to Collection
2008 Mar Others Fist_Author_Year_PM

Full Author : ['Mandal, Uttam', 'Pal, Tapan Kumar']
Journal Title : Drug development and industrial pharmacy
Chapter : Section3
Journal Year : 2008
Cited by : Not Available

The emerging new fixed dose combination of metformin hydrocholride (HCl) as sustained release and glipizide as immediate release were formulated as a bilayer matrix tablet using hydroxy propyl methyl cellulose (HPMC) as the matrix-forming polymer, and the.....

Keywords : ["bilayer matrix tablet contain metformin hcl", "vitro study", "sustain release", "immediate release", "fixeddose combination", "glipizide", "formulation"]